NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered MOTS-c from Guangzhou Aoyu? Mail in a sample (US only) and let us test it.

Test my supply
+1 more ↓
27%
Finnrick rating
#10 of 20 MOTS-c vendors
0 of 2 classifiable tests passed
natural 0% · customers 4.5★ (2)
methodology · Purity focus
Finnrick analysis · MOTS-c

Guangzhou Aoyu's purity-focus record is narrow and mixed, with Tirzepatide showing earlier clean 99.9% purity results but no broader peptide coverage. Recent Tirzepatide evidence is highly dispersed, as repeated June identity failures with 0% purity and no fill offset one clean mid-June result.

methodology →
vendor intelligence report
Vendor Intelligence Report: Guangzhou Aoyu

Corporate records put the peptide storefront on a platform-only GlobalSources profile while older Aoyu listings sell unrelated goods. The report maps the identity stack, manufacturer-claim conflicts, missing credential trail, and clean-but-limited promotion sweep.

19 pages4 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.82
81%
3
2
Tirzepatide
$0.40
73%
8
3
Tesamorelin
$1.45
41%
3
4
MOTS-cselected
-
27%
2
6
GHK-Cu
$0.10
-
0
9
PT-141
-
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%20 May 2026: 39%8 Jun 2026: 40%29 Sept 2026: current 27%39%27%May 26Sep 26
Showing MOTS-c tests only
Guangzhou Aoyu MOTS-c test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
8 Jun 2026Fail
Tested
lab nameView COA
20 May 2026Fail
Tested
lab nameView COA

About Guangzhou Aoyu test results from Finnrick

Guangzhou Aoyu is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 16 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Guangzhou Aoyu peptides in this dataset are MOTS-c (2 tests), Retatrutide (3 tests) and Tesamorelin (3 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 16 recent tests.

Corrections
No corrections.
Peptide testing

Ordered MOTS-c from Guangzhou Aoyu? Mail in a sample (US only) and let us test it.

Test my supply